Memory activation reveals abnormal EEG in preclinical Huntington's disease

Movement Disorders

Volumn 22, Issue 5, 2007, Pages 690-695

  Van Der Hiele, Karin ^a,b   Jurgens, Caroline K ^a   Vein, Alla A ^b   Reijntjes, Robert H A M ^b   Witjes Ané, Marie Noëlle W ^a   Roos, Raymund A C ^b   Van Dijk, Gert ^b   Middelkoop, Huub A M ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

EEG; Huntington's disease; Memory activation; Neuropsychology; Preclinical

Indexed keywords

ADULT; ALPHA RHYTHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; EYELID CLOSURE; FEMALE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCORING SYSTEM; THETA RHYTHM; WORKING MEMORY;

ADULT; ALPHA RHYTHM; CEREBRAL CORTEX; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FEMALE; HETEROZYGOTE DETECTION; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; THETA RHYTHM; TRINUCLEOTIDE REPEATS;

EID: 34249109974     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21390     Document Type: Article

References (29)

1. Paulsen JS, Zhao H, Stout JC, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001;57:658-662.
2. Witjes-Ane MN, Vegter-van der Vlis M, van Vugt JPP, et al. Cognitive and motor functioning in gene carriers for Huntington's disease: A baseline study. J Neuropsychiatry Clin Neurosci 2003;15:7-16.
3. Close Kirkwood S, Siemers E, Viken RJ, et al. Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales. J Psychiatr Res 2002;36:377-382.
4. Streletz LJ, Reyes PF, Zalewska M, Katz L, Fariello RG. Computer analysis of EEG activity in dementia of the Alzheimer's type and Huntington's disease. Neurobiol Aging 1990;11:15-20.
5. Bylsma FW, Peyser CE, Folstein SE, Folstein MF, Ross C, Brandt J. EEG power spectra in Huntington's disease: clinical and neuropsychological correlates. Neuropsychologia 1994;32:137-150.
6. Bellotti R, De Carlo F, Massafra R, de Tommaso M, Sciruicchio V. Topographic classification of EEG patterns in Huntington's disease. Neurol Clin Neurophysiol 2004;37.
7. de Tommaso M, De Carlo F, Difruscolo O, Massafra R, Sciruicchio V, Bellotti R. Detection of subclinical brain electrical activity changes in Huntington's disease using artificial neural networks. Clin Neurophysiol 2003;114:1237-1245.
8. Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T. Subtle changes among presymptomatic carriers of the Huntington's disease gene. J Neurol Neurosurg Psychiatry 2000;69:773-779.
9. Olichney JM, Morris SK, Ochoa C, et al. Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002;73:377-384.
10. Pijnenburg YA, Made Y, van Cappellen van Walsum AM, Knol DL, Scheltens P, Stam CJ. EEG synchronization likelihood in mild cognitive impairment and Alzheimer's disease during a working memory task. Clin Neurophysiol 2004;115:1332-1339.
11. van der Hiele K, Vein AA, Kramer CGS, et al. Memory activation enhances EEG abnormality in mild cognitive impairment. Neurobiol Aging 2007;28:85-90.
12. Huntington Study Group. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996;11:136-142.
13. International Huntington Association and World Federation of Neurology. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1999;44:1533-1536.
14. American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. ACMG/ASHG statement: laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 1998;62:1243-1247.
15. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Wechsler DA. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
17. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
18. Smith A. The symbol digit modalities test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 1968;3:91.
19. Benton AL, Hamsher KD. Multilingual aphasia examination. Iowa City, IA: AJA Associates; 1989.
20. Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psychometrika 1959;32:95-112.
21. Rosas HD, Feigin AS, Hersch SM. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's Disease. Neurorx 2004;1:263-272.
22. Bamford KA, Caine ED, Kido DK, Cox C, Shoulson I. A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Neurology 1995;45:1867-1873.
23. Hughes SW, Crunelli V. Thalamic mechanisms of EEG α Rhythms and their pathological implications. Neuroscientist 2005;11:357-372.
24. Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB. Thalamic atrophy in Huntington's disease covaries with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005;15:846-853.
25. Mann DM, Oliver R, Snowden JS. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol (Berlin) 1993;85:553-559.
26. Starkstein SE, Brandt J, Bylsma F, Peyser C, Folstein M, Folstein SE. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study. Neuroradiology 1992;34:487-489.
27. Klimesch W. EEG α and θ oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev 1999;29:169-195.
28. Sishta SK, Troupe A, Marszalek KS, Kremer LM. Huntington's chorea: an electroencephalographic and psychometric study. Electroencephalogr Clin Neurophysiol 1974;36:387-393.
29. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - a longitudinal follow-up study. J Neurol 2004;251:935-942.